Recent Quotes

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-10
REV		(EXPECTED)2021-08-10

Q1 2021		Est.		Actual		Surprise
EPS		-0.100		-0.130		-0.0300
REV		2.120M		34.000K		-2.086M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
CLSD	Clearside Biomedical	5.17	0.10	1.97%		297.7M

Clearside Biomedical Frequently Asked Questions

How do I buy Clearside Biomedical (CLSD) stock?

You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.

View our list of the best stock brokerages.

Who are Clearside Biomedical's (CLSD) competitors?

Other companies in Clearside Biomedical’s space includes: Verona Pharma (NASDAQ:VRNA), BioDelivery Sciences Intl (NASDAQ:BDSI), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY) and ANI Pharmaceuticals (NASDAQ:ANIP).

What is the target price for Clearside Biomedical (CLSD) stock?

The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by Wedbush on June 17, 2021. The analyst firm set a price target for 18.00 expecting CLSD to rise to within 12 months (a possible 248.16% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Clearside Biomedical (CLSD)?

The stock price for Clearside Biomedical (NASDAQ: CLSD) is $5.17 last updated Today at 7:33:59 PM.

Does Clearside Biomedical (CLSD) pay a dividend?

There are no upcoming dividends for Clearside Biomedical.

When is Clearside Biomedical (NASDAQ:CLSD) reporting earnings?

Clearside Biomedical’s Q2 earnings are confirmed for after-market on August 10, 2021.

Is Clearside Biomedical (CLSD) going to split?

There is no upcoming split for Clearside Biomedical.

What sector and industry does Clearside Biomedical (CLSD) operate in?

Clearside Biomedical is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.